Lidotral 3.88% Roll on (lidocaine hci) NDC 59088-307

NDC codes

FDA NDC Directory

Product NDC (as listed)59088-307Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59088-0307Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59088-307-07	59088030707	85 g in 1 BOTTLE (59088-307-07)Marketed from Feb 28, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidotral 3.88% Roll on
Generic name (nonproprietary): lidocaine hci
Active ingredients: Lidocaine hydrochloride — 38.8 mg/g
Dosage form: Gel
Route: Topical
Labeler: PureTek Corporation
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Feb 28, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 59088-307_db1085fe-0a1e-c4cc-e053-2a95a90aa838SPL ID db1085fe-0a1e-c4cc-e053-2a95a90aa838SPL set ID db1085fe-0a1f-c4cc-e053-2a95a90aa838RxCUI 2675768, 2675772UNII V13007Z41A
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459088030707 followed by a unit qualifier and the quantity

Package 59088-0307-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2024.

Indications (excerpt from the label)

INDICATIONS For the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)